Cardlytics Inc reports results for the quarter ended in March - Earnings Summary

Cardlytics

09/05/2024 18:08

* Cardlytics Inc  CDLX.OQ  reported a quarterly adjusted
loss of 9
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -25
cents.  The mean expectation of three analysts for the quarter
was for a loss of 11 cents per share. Wall Street expected
results to range from -20 cents to -1 cents per share.
    * Revenue rose 5.1% to $67.61 million from a year ago;
analysts
expected $71.69 million. 
    * Cardlytics Inc's reported EPS for the quarter was a loss
of 56
cents​.
    * The company reported a quarterly loss of $24.28 million.
    * Cardlytics Inc shares had risen by 0.8% this quarter and
gained 58.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 48.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the software peer
group
is also "buy"

Wall Street's median 12-month price target for Cardlytics Inc is
$18.00 
This summary was machine generated from LSEG data May 9 at 05:08
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.11          -0.09          Beat
 Dec. 31 2023      0.12           0.14           Beat
 Sep. 30 2023      -0.01          0.01           Beat
 Jun. 30 2023      -0.35          -0.24          Beat